Comprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitors

References

• Atkins, P. W. (1987). Molecules. Scientific American Library.
   Google Scholar
• Avram, S. I., Crisan, L., Bora, A., Pacureanu, L. M., Avram, S., & Kurunczi, L. (2013). Retrospective group fusion similarity search based on eROCE evaluation metric. Bioorganic & Medicinal Chemistry, 21(5), 1268–1278. doi:10.1016/j.bmc.2012.12.041
   PubMed Web of Science ®Google Scholar
• Avram, S. I., Pacureanu, L. M., Bora, A., Crisan, L., Avram, S., & Kurunczi, L. (2014). ColBioS-FlavRC: A collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes. Journal of Chemical Information and Modeling, 54(8), 2360–2370. doi:10.1021/ci5002668
   PubMed Web of Science ®Google Scholar
• Avram, S., Pacureanu, L. M., Seclaman, E., Bora, A., & Kurunczi, L. (2011). PLS-DA-docking optimized combined energetic terms (PLSDA-DOCET) protocol: A brief evaluation. Journal of Chemical Information and Modeling, 51(12), 3169–3179. doi:10.1021/ci2002268
   PubMed Web of Science ®Google Scholar
• Bajorath, J. (2008). Computational analysis of ligand relationships within target families. Current Opinion in Chemical Biology, 12(3), 352–358. doi:10.1016/j.cbpa.2008.01.044
   PubMed Web of Science ®Google Scholar
• Ballester, P. J., & Richards, W. G. (2007). Ultrafast shape recognition to search compound databases for similar molecular shapes. Journal of Computational Chemistry, 28(10), 1711–1723. doi:10.1002/jcc.20681
   PubMed Web of Science ®Google Scholar
• Bemis, G. W., & Murcko, M. A. (1996). The properties of known drugs.1. Molecular frameworks. Journal of Medicinal Chemistry, 39(15), 2887–2893. doi:10.1021/jm9602928
   PubMed Web of Science ®Google Scholar
• Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., Nowotka, M., Papadatos, G., Santos, R., & Overington, J. P. (2014). The ChEMBL bioactivity database: An update. Nucleic Acids Research, 42(D1), D1083–1090. doi:10.1093/nar/gkt1031
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. doi:10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Bertrand, J. A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H. M., & Flocco, M. (2003). Structural characterization of the GSK-3beta active site using selective and non-selective ATP-mimetic inhibitors. Journal of Molecular Biology, 333(2), 393–407. doi:10.1016/j.jmb.2003.08.031
   PubMed Web of Science ®Google Scholar
• BIOVIA Release 4.5. (2016). Discovery studio visualizer. Dassault Systèmes.
   Google Scholar
• Bissantz, C., Folkers, G., & Rognan, D. (2000). Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. Journal of Medicinal Chemistry, 43(25), 4759–4767. 10.1021/jm001044l
   PubMed Web of Science ®Google Scholar
• Black, A. R., & Black, J. D. (2013). Protein kinase C signaling and cell cycle regulation. Frontiers in Immunology, 3, 423. doi:10.3389/fimmu.2012.00423
   PubMed Web of Science ®Google Scholar
• Bortolato, A., Perruccio, F., & Moro, S. (2011). In M. A. Miteva (Ed.), In-silico lead discovery. Bentham Science Publishers eBook.
   Google Scholar
• Bregman, H., Williams, D. S., Atilla, G. E., Carroll, P. J., & Meggers, E. (2004). An organometallic inhibitor for glycogen synthase kinase-3. Journal of the American Chemical Society, 126(42), 13594–13595. doi:10.1021/ja046049c
   PubMed Web of Science ®Google Scholar
• Cabani, S., Gianni, P., Mollica, V., & Lepori, L. (1981). Group contributions to the thermodynamic properties of non-ionic organic solutes in dilute aqueous solution. Journal of Solution Chemistry, 10(8), 563–595. DOIdoi:10.1007/BF00646936
   Web of Science ®Google Scholar
• Chang, C. E., Chen, W., & Gilson, M. K. (2007). Ligand configurational entropy and protein binding. Proceedings of the National Academy of Sciences of Sciences, 104(5), 1534–1539. doi:10.1073/pnas.0610494104
   PubMed Web of Science ®Google Scholar
• Chen, J., Zhang, X., & Fernandez, A. (2007). Molecular basis for specificity in the druggable kinome: Sequence-based analysis. Bioinformatics, 23(5), 563–572. doi:10.1093/bioinformatics/btl666
   PubMed Web of Science ®Google Scholar
• Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014). Lessons learned from the fate of AstraZeneca’s drug pipeline: A five-dimensional framework. Nature Reviews Drug Discovery, 13(6), 419–431. doi:10.1038/nrd4309
   PubMed Web of Science ®Google Scholar
• Crisan, L., Avram, S., Kurunczi, L., & Pacureanu, L. M. (2020). Partial Least Squares Discriminant Analysis and 3D Similarity perspective applied to analyze comprehensively the selectivity of Glycogen Synthase Kinase 3. Molecular Informatics, 39, 1900142. doi:10.1002/minf.201900142
   Web of Science ®Google Scholar
• Crisan, L., Avram, S., & Pacureanu, L. M. (2017). Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors. Molecular Diversity, 21(2), 385–405. doi:10.1007/s11030-016-9724-5
   PubMed Web of Science ®Google Scholar
• Crisan, L., Pacureanu, L., Avram, A., Bora, A., Avram, S., & Kurunczi, L. (2014). PLS and shape-based similarity analysis of maleimides–GSK-3 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(4), 599–610. doi:10.3109/14756366.2013.833196
   PubMed Web of Science ®Google Scholar
• Crisan, L., Pacureanu, L., Bora, A., Avram, S., Kurunczi, L., & Simon, Z. (2013). QSAR study and molecular docking on indirubin inhibitors of Glycogen Synthase Kinase-3. Central European Journal of Chemistry, 11(1), 63–77. doi:10.2478/s11532-012-0133-z
   Google Scholar
• Development Core Team R. (2012). R: a language and environment for statistical computing. R Foundation for Statistical Computing. http://www.R-project.org/
   Google Scholar
• Ebalunode, J. O., Ouyang, Z., Liang, J., & Zheng, W. (2008). Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques. Journal of Chemical Information and Modeling, 48(4), 889–901. doi:10.1021/ci700368p
   PubMed Web of Science ®Google Scholar
• Ellis, D., Furner-Hines, J., & Willett, P. (1993). On the measurement of inter-linker consistency and retrieval effectiveness in hypertext databases. Perspective on Information Management, 3, 128–149. doi:10.1007/978-1-4471-2099-5_6
   Google Scholar
• Engler, T. A., Malhotra, S., Burkholder, T. P., Henry, J. R., Mendel, D., Porter, W. J., Furness, K., Diefenbacher, C., Marquart, A., Reel, J. K., Li, Y., Clayton, J., Cunningham, B., McLean, J., O’Toole, J. C., Brozinick, J., Hawkins, E., Misener, E., Briere, D., … Cook, J. A. (2005). The development of potent and selective bisarylmaleimide GSK3 inhibitors. Bioorganic & Medicinal Chemistry Letters, 15(4), 899–903. doi:10.1016/j.bmcl.2004.12.063
   PubMed Web of Science ®Google Scholar
• Feng, L., Geisselbrecht, Y., Blanck, S., Wilbuer, A., Atilla-Gokcumen, G. E., Filippakopoulos, P., KräLing, K., Celik, M. A., Harms, K., Maksimoska, J., Marmorstein, R., Frenking, G., Knapp, S., Essen, L.-O., & Meggers, E. (2011). Structurally sophisticated octahedral metal complexes as highly selective protein kinase inhibitors. Journal of the American Chemical Society, 133(15), 5976–5986. doi:10.1021/ja1112996
   PubMed Web of Science ®Google Scholar
• FRED version 3.2.0.2. (2013). OpenEye Scientific Software. http://www.eyesopen.com
   Google Scholar
• Freitas, R. F., Oprea, T. I., & Montanari, C. A. (2008). 2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L. Bioorganic & Medicinal Chemistry, 16(2), 838–853. doi:10.1016/j.bmc.2007.10.048
   PubMed Web of Science ®Google Scholar
• Gaisina, I. N., Gallier, F., Ougolkov, A. V., Kim, K. H., Kurome, T., Guo, S., Holzle, D., Luchini, D. N., Blond, S. Y., Billadeau, D. D., & Kozikowski, A. P. (2009). From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells. Journal of Medicinal Chemistry, 52(7), 1853–1863. doi:10.1021/jm801317h
   PubMed Web of Science ®Google Scholar
• Good, A. C., & Oprea, T. I. (2008). Optimization of CAMD techniques 3. Virtual screening enrichment studies: A help or hindrance in tool selection? Journal of Computer-Aided Molecular Design, 22(3–4), 169–178. − doi:10.1007/s10822-007-9167-2
   PubMed Web of Science ®Google Scholar
• Graff, J. R., McNulty, A. M., Hanna, K. R., Konicek, B. W., Lynch, R. L., Bailey, S. N., Banks, C., Capen, A., Goode, R., Lewis, J. E., Sams, L., Huss, K. L., Campbell, R. M., Iversen, P. W., Neubauer, B. L., Brown, T. J., Musib, L., Geeganage, S., & Thornton, D. (2005). The protein kinase Cβ–selective inhibitor, enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Research, 65(16), 7462–7469. doi:10.1158/0008-5472.CAN-05-0071
   PubMed Web of Science ®Google Scholar
• Gürsoy, O., & Smieško, M. (2017). Searching for bioactive conformations of drug-like ligands with current force fields: How good are we? Journal of Cheminformatics, 9(1), 29. doi:10.1186/s13321-017-0216-0
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (1999). MMFF VI. MMFF94s option for energy minimization studies. Journal of Computational Chemistry, 20(7), 720–729.(SICI)1096-987X(199905)20:7 < 720::AID-JCC7 > 3.0.CO;2-X doi:10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X
   PubMed Web of Science ®Google Scholar
• Hanley, J. A., & McNeil, B. J. (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), 29–36. doi:10.1148/radiology.143.1.7063747
   PubMed Web of Science ®Google Scholar
• Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., & Polakis, P. (1998). Downregulation of beta-catenin by human axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Current Biology, 8(10), 573–581. doi:10.1016/S0960-9822(98)70226-X
   PubMed Web of Science ®Google Scholar
• Hawkins, P. C. D., & Nicholls, A. (2012). Conformer generation with OMEGA: Learning from the data set and the analysis of failures. Journal of Chemical Information and Modeling, 52(11), 2919–2936. doi:10.1021/ci300314k
   PubMed Web of Science ®Google Scholar
• Hawkins, P. C. D., Skillman, A. G., & Nicholls, A. (2007). Comparison of shape-matching and docking as virtual screening tools. Journal of Medicinal Chemistry, 50(1), 74–82. doi:10.1021/jm0603365
   PubMed Web of Science ®Google Scholar
• Hawkins, P. C. D., Skillman, A. G., Warren, G. L., Ellingson, B. A., & Stahl, M. T. (2010). Conformer generation with OMEGA: Algorithm and validation using high quality structures from the protein databank and Cambridge structural database. Journal of Chemical Information and Modeling, 50(4), 572–584. doi:10.1021/ci100031x
   PubMed Web of Science ®Google Scholar
• Hellerstein, M. K. (2008). Exploiting complexity and the robustness of network architecture for drug discovery. Journal of Pharmacology and Experimental Therapeutics, 325(1), 1–9. doi:10.1124/jpet.107.131276
   PubMed Web of Science ®Google Scholar
• Hevener, K. E., Zhao, W., Ball, D. M., Babaoglu, K., Qi, J., White, S. W., & Lee, R. E. (2009). Validation of molecular docking programs for virtual screening against dihydropteroate synthase. Journal of Chemical Information and Modeling, 49(2), 444–460. doi:10.1021/ci800293n
   PubMed Web of Science ®Google Scholar
• Hili, R., & Yudin, A. K. (2006). Making carbon-nitrogen bonds in biological and chemical synthesis. Nature Chemical Biology, 2(6), 284–287. doi:10.1038/nchembio0606-284
   PubMed Web of Science ®Google Scholar
• Hong, M., Chen, D. C., Klein, P. S., & Lee, V. M. (1997). Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. Journal of Biological Chemistry, 272(40), 25326–25332. doi:10.1074/jbc.272.40.25326
   PubMed Web of Science ®Google Scholar
• Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682–690. doi:10.1038/nchembio.118
   PubMed Web of Science ®Google Scholar
• Huang, N., Shoichet, B. K., & Irwin, J. J. (2006). Benchmarking sets for molecular docking. Journal of Medicinal Chemistry, 49(23), 6789–6801. doi:10.1021/jm0608356
   PubMed Web of Science ®Google Scholar
• Ibrahim, T. M., Bauer, M. R., & Boeckler, F. M. (2015). Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization. Journal of Cheminformatics, 7(1), 21. 10.1186/s13321-015-0074-6
   PubMed Web of Science ®Google Scholar
• Instant JChem version 5.12.4. (2013). ChemAxon. http://www.chemaxon.com
   Google Scholar
• Irwin, J. J. (2008). Community benchmarks for virtual screening. Journal of Computer-Aided Molecular Design, 22(3–4), 193–199. − doi:10.1007/s10822-008-9189-4
   PubMed Web of Science ®Google Scholar
• Iwase, K., & Hirono, S. (1999). Estimation of active conformations of drugs by a new molecular superposing procedure. Journal of Computer-Aided Molecular Design, 13(5), 499–512. DOI 10.1023/A:1008011422113
   PubMed Web of Science ®Google Scholar
• Jeffrey, G. A. (1997). An introduction to hydrogen bonding. Oxford University Press.
   Google Scholar
• Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007). Glycogen Synthase Kinase-3 (GSK3): Inflammation. Neurochemical Research, 32(4–5), 577–595. doi:10.1007/s11064-006-9128-5
   PubMed Web of Science ®Google Scholar
• Katritzky, A. R., Pacureanu, L., Slavov, S., Dobchev, D. A., & Karelson, M. (2006). QSAR study of antiplatelet agents. Bioorganic & Medicinal Chemistry, 14(22), 7490–7500. − doi:10.1016/j.bmc.2006.07.022
   PubMed Web of Science ®Google Scholar
• Kawasaki, Y., & Freire, E. (2011). Finding a better path to drug selectivity. Drug Discovery Today, 16(21–22), 985–990. doi:10.1016/j.drudis.2011.07.010
   PubMed Web of Science ®Google Scholar
• Kelley, B. P., Brown, S. P., Warren, G. L., & Muchmore, S. W. (2015). POSIT: Flexible shape-guided docking for pose prediction. Journal of Chemical Information and Modeling, 55(8), 1771–1780. doi:10.1021/acs.jcim.5b00142
   PubMed Web of Science ®Google Scholar
• Knight, Z. A., & Shokat, K. M. (2005). Features of selective kinase inhibitors. Chemistry & Biology, 12(6), 621–637. doi:10.1016/j.chembiol.2005.04.011
   PubMed Web of Science ®Google Scholar
• Kortagere, S., Krasowski, M. D., & Ekins, S. (2009). The importance of discerning shape in molecular pharmacology. Trends in Pharmacological Sciences, 30(3), 138–147. doi:10.1016/j.tips.2008.12.00
   PubMed Web of Science ®Google Scholar
• Kozikowski, A. P., Gunosewoyo, H., Guo, S., Gaisina, I. N., Walter, R. L., Ketcherside, A., McClung, C. A., Mesecar, A. D., & Caldarone, B. (2011). Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice. Chemmedchem. , 6(9), 1593–1602. doi:10.1002/cmdc.201100188
   PubMed Web of Science ®Google Scholar
• Kramer, T., Schmidt, B., & Lo Monte, F. (2012). Small-Molecule Inhibitors of GSK-3: Structural insights and their application to Alzheimer’s disease models. International Journal of Alzheimer's Disease, 2012, 1–32. doi:10.1155/2012/381029
   Google Scholar
• Lal, H., Ahmad, F., Woodgett, J., & Force, T. (2015). The GSK-3 family as therapeutic target for myocardial diseases. Circulation Research, 116(1), 138–149. doi:10.1161/CIRCRESAHA.116.303613
   PubMed Web of Science ®Google Scholar
• Lanctot, J. K., Putta, S., Lemmen, C., & Greene, J. (2003). Using ensembles to classify compounds for drug discovery. Journal of Chemical Information and Computer Sciences, 43(6), 2163–2169. doi:10.1021/ci034129e
   PubMedGoogle Scholar
• Lesuisse, D., Dutruc-Rosset, G., Tiraboschi, G., Dreyer, M. K., Maignan, S., Chevalier, A., Halley, F., Bertrand, P., Burgevin, M.-C., Quarteronet, D., & Rooney, T. (2010). Rational design of potent GSK3β inhibitors with selectivity for Cdk1 and Cdk2. Bioorganic & Medicinal Chemistry Letters, 20(6), 1985–1989. doi:10.1016/j.bmcl.2010.01.114
   PubMed Web of Science ®Google Scholar
• Levin, J. (2014). Macrocycles in drug discovery. Cambridge, UK: Royal Society of Chemistry. doi:10.1039/9781782623113
   Google Scholar
• LigPrep. (2014). Schrödinger, LLC. https://www.schrodinger.com/ligprep
   Google Scholar
• Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007). BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research, 35(Database), D198–201. doi:10.1093/nar/gkl999
   PubMed Web of Science ®Google Scholar
• McGann, M. (2011). FRED pose prediction and virtual screening accuracy. Journal of Chemical Information and Modeling, 51(3), 578–596. doi:10.1021/ci100436p
   PubMed Web of Science ®Google Scholar
• McGann, M. (2012). Comparison of topological, shape, and docking methods in virtual screening. Journal of Computer-Aided Molecular Design, 26(8), 897–906. doi:10.1007/s10822-012-9584-8
   PubMed Web of Science ®Google Scholar
• McGann, M. R., Almond, H. R., Nicholls, A., Grant, J. A., & Brown, F. K. (2003). Gaussian docking functions. Biopolymers, 68(1), 76–90. doi:10.1002/bip.10207
   PubMed Web of Science ®Google Scholar
• Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594. doi:10.1021/jm300687e
   PubMed Web of Science ®Google Scholar
• OMEGA version 2.5.1.4. (2013). OpenEye Scientific Software. http://www.eyesopen.com.
   Google Scholar
• Oniga, S. D., Pacureanu, L., Stoica, C. I., Palage, M. D., Crăciun, A., Rusu, L. R., Crisan, E. L., & Araniciu, C. (2017). COX inhibition profile and molecular docking studies of some 2-(trimethoxyphenyl)-thiazoles. Molecules, 22(9), 1507. doi:10.3390/molecules22091507
   Web of Science ®Google Scholar
• Oprea, T. I., Bologa, C. G., Boyer, S., Curpan, R. F., Glen, R. C., Hopkins, A. L., Lipinski, C. A., Marshall, G. R., Martin, Y. C., Ostopovici-Halip, L., Rishton, G., Ursu, O., Vaz, R. J., Waller, C., Waldmann, H., & Sklar, L. A. (2009). A crowdsourcing evaluation of the NIH chemical probes. Nature Chemical Biology, 5(7), 441–447. doi:10.1038/nchembio0709-441
   PubMed Web of Science ®Google Scholar
• Pacureanu, L., Avram, S., Bora, A., Kurunczi, L., & Crisan, L. (2019). Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and docking. Structural Chemistry, 30(3), 911–923. doi:10.1007/s11224-018-1224-z
   Web of Science ®Google Scholar
• Pande, V., & Ramos, M. J. (2005). Structural basis for the GSK-β binding affinity and selectivity against CDK-2 of 1-(4-aminofurazan-3yl)-5-dialkylaminomethyl-1H-1,2,3] triazole-4-carboxylic acid derivatives. Bioorganic & Medicinal Chemistry Letters, 15(23), 5129–5135. doi:10.1016/j.bmcl.2005.08.077
   PubMed Web of Science ®Google Scholar
• Pantsar, T., & Poso, A. (2018). Binding Affinity via Docking: Fact and fiction. Molecules, 23(8), 1899. doi:10.3390/molecules23081899
   PubMed Web of Science ®Google Scholar
• Patel, R. Y., & Doerksen, R. J. (2010). Protein kinase-inhibitor database: Structural variability of and inhibitor interactions with the protein kinase P-loop. Journal of Proteome Research, 9(9), 4433–4442. doi:10.1021/pr100662s
   PubMed Web of Science ®Google Scholar
• Quattropani, A., Sauer, W. H. B., Crosignani, S., Dorbais, J., Gerber, P., Gonzalez, J., Marin, D., Muzerelle, M., Beltran, F., Nichols, A., Georgi, K., Schneider, M., Vitte, P.-A., Eligert, V., Novo-Perez, L., Hantson, J., Nock, S., Carboni, S., de Souza, A. L. S., … Bombrun, A. (2015). Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy. Chemmedchem. , 10(4), 688–714. doi:10.1002/cmdc.201402557
   PubMed Web of Science ®Google Scholar
• RCSB Protein Data Bank. Retrieved December 2018, from https://www.rcsb.org/
   Google Scholar
• Richardson, C. M., Nunns, C. L., Williamson, D. S., Parratt, M. J., Dokurno, P., Howes, R., Borgognoni, J., Drysdale, M. J., Finch, H., Hubbard, R. E., Jackson, P. S., Kierstan, P., Lentzen, G., Moore, J. D., Murray, J. B., Simmonite, H., Surgenor, A. E., & Torrance, C. J. (2007). Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping. Bioorganic & Medicinal Chemistry Letters, 17(14), 3880–3885. doi:10.1016/j.bmcl.2007.04.110
   PubMed Web of Science ®Google Scholar
• ROCS version 3.2.1.4. (2013). OpenEye Scientific Software. http://www.eyesopen.com.
   Google Scholar
• Rohrer, S. G., & Baumann, K. (2009). Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data. Journal of Chemical Information and Modeling, 49(2), 169–184. doi:10.1021/ci8002649
   PubMed Web of Science ®Google Scholar
• Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005). A shape-based 3D scaffold hopping method and its application to a bacterial protein-protein interaction. Journal of Medicinal Chemistry, 48(5), 1489–1495. doi:10.1021/jm040163o
   PubMed Web of Science ®Google Scholar
• Schneider, G., Neidhart, W., Giller, T., & Schmid, G. (1999). Scaffold-Hopping” by topological pharmacophore search: A contribution to virtual screening. Angewandte Chemie International Edition, 38(19), 2894–2896. doi:10.1002/(SICI)1521-3773(19991004)38:19 < 2894::AID-ANIE2894 > 3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Sheridan, R. P., McGaughey, G. B., & Cornell, W. D. (2008). Multiple protein structures and multiple ligands: Effects on the apparent goodness of virtual screening results. Journal of Computer-Aided Molecular Design, 22(3-4), 257–265. doi:10.1007/s10822-008-9168-9
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., & Roberts, J. M. (2004). Living with or without cyclins and cyclin-dependent kinases. Genes & Development, 18(22), 2699–2711. doi:10.1101/gad.1256504
   PubMed Web of Science ®Google Scholar
• Smyth, L. A., & Collins, I. (2009). Measuring and interpreting the selectivity of protein kinase inhibitors. Journal of Chemical Biology, 2(3), 131–151. doi:10.1007/s12154-009-0023-9
   PubMedGoogle Scholar
• STATISTICA 7.1. (2005). Tulsa, StatSoft Inc.
   Google Scholar
• Stumpfe, D., Geppert, H., & Bajorath, J. (2008). Methods for computer-aided chemical biology. part 3: Analysis of structure-selectivity relationships through single- or dual-step selectivity searching and bayesian classification. Chemical Biology & Drug Design, 71(6), 518–528. doi:10.1111/j.1747-0285.2008.00670.x
   PubMed Web of Science ®Google Scholar
• Stumpfe, D., Lounkine, E., & Bajorath, J. (2011). Molecular test systems for computational selectivity studies and systematic analysis of compound selectivity profiles. Methods in Molecular Biology, 672, 503–516. doi: 10.1007/978-1-60761-839-3_20
   PubMedGoogle Scholar
• Sutherland, J. J., Nandigam, R. K., Erickson, J. A., & Vieth, M. (2007). Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracy. Journal of Chemical Information and Modeling, 47(6), 2293–2302. doi:10.1021/ci700253h
   PubMed Web of Science ®Google Scholar
• Thimm, M., Goede, A., Hougardy, S., & Preissner, R. (2004). Comparison of 2D similarity and 3D superposition. Application to searching a conformational drug database. Journal of Chemical Information and Computer Sciences, 44(5), 1816–1822. doi:10.1021/ci049920h
   PubMedGoogle Scholar
• Truchon, J. F., & Bayly, C. I. (2007). Evaluating virtual screening methods: Good and bad metrics for the “early recognition” problem. Journal of Chemical Information and Modeling, 47(2), 488–508. doi:10.1021/ci600426e
   PubMed Web of Science ®Google Scholar
• Venhorst, J., Núñez, S., Terpstra, J. W., & Kruse, C. G., (2008). Assessment of scaffold hopping efficiency by use of molecular interaction fingerprints. Journal of Medicinal Chemistry, 51(11), 3222–3229. doi:10.1021/jm8001058
   PubMed Web of Science ®Google Scholar
• Verdonk, M. L., Berdini, V., Hartshorn, M. J., Mooij, W. T. M., Murray, C. W., Taylor, R. D., & Watson, P. (2004). Virtual Screening Using Protein − Ligand Docking: Avoiding Artificial Enrichment. Journal of Chemical Information and Computer Sciences, 44(3), 793–806. doi:10.1021/ci034289q
   PubMedGoogle Scholar
• Vogt, I., Stumpfe, D., Ahmed, H. E. A., & Bajorath, J. (2007). Methods for computer-aided chemical biology. part 2: Evaluation of compound selectivity using 2d molecular fingerprints. Chemical Biology & Drug Design, 70(3), 195–205. doi:10.1111/j.1747-0285.2007.00555.x
   PubMed Web of Science ®Google Scholar
• Wagner, F. F., Bishop, J. A., Gale, J. P., Shi, X., Walk, M., Ketterman, J., Patnaik, D., Barker, D., Walpita, D., Campbell, A. J., Nguyen, S., Lewis, M., Ross, L., Weïwer, M., An, W. F., Germain, A. R., Nag, P. P., Metkar, S., Kaya, T., … Pan, J. Q. (2016). Inhibitors of glycogen synthase kinase 3 with exquisite kinome-wide selectivity and their functional effects. ACS Chemical Biology, 11(7), 1952–1963. doi:10.1021/acschembio.6b00306
   PubMed Web of Science ®Google Scholar
• Wang, Y., Suzek, T., Zhang, J., Wang, J., He, S., Cheng, T., Shoemaker, B. A., Gindulyte, A., & Bryant, S. H. (2014). PubChem BioAssay: 2014. Nucleic Acids Research, 42(D1), D1075–D1082. doi:10.1093/nar/gkt978]
   PubMed Web of Science ®Google Scholar
• Wang, Z., Xie, Y., Zhang, L., Zhang, H., An, X., Wang, T., & Meng, A. (2008). Migratory localization of cyclin D2-Cdk4 complex suggests a spatial regulation of the G1-S transition. Cell Structure and Function, 33(2), 171–183. doi:10.1247/csf.08019
   PubMed Web of Science ®Google Scholar
• Welsh, G. I., Miller, C. M., Loughlin, A. J., Price, N. T., & Proud, C. G. (1998). Regulation of eukaryotic initiation factor eIF2B: Glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Letters, 421(2), 125–130. doi:10.1016/S0014-5793(97)01548-2
   PubMed Web of Science ®Google Scholar
• Whittle, M., Gillet, V. J., Willett, P., Alex, A., & Loesel, J. (2004). Enhancing the effectiveness of virtual screening by fusing nearest neighbor lists: A comparison of similarity coefficients. Journal of Chemical Information and Computer Sciences, 44(5), 1840–1848. pmid:15446844
   PubMedGoogle Scholar
• Xia, J., Jin, H., Liu, Z., Zhang, L., & Wang, X. S. (2014). An Unbiased Method to Build Benchmarking Sets for Ligand-Based Virtual Screening and its Application to GPCRs. Journal of Chemical Information and Modeling, 54(5), 1433–1450. doi:10.1021/ci500062f
   PubMed Web of Science ®Google Scholar
• Xiao, W., Wang, D., Shen, Z., Li, S., & Li, H. (2018). Multi-Body Interactions in Molecular Docking Program Devised with Key Water Molecules in Protein Binding Sites. Molecules, 23(9), 2321. doi:10.3390/molecules23092321
   PubMed Web of Science ®Google Scholar
• Xing, L., Shieh, H. S., Selness, S. R., Devraj, R. V., Walker, J. K., Devadas, B., Hope, H. R., Compton, R. P., Schindler, J. F., Hirsch, J. L., Benson, A. G., Kurumbail, R. G., Stegeman, R. A., Williams, J. M., Broadus, R. M., Walden, Z., & Monahan, J. B. (2009). Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804. Biochemistry, 48(27), 6402–6411. doi:10.1021/bi900655f
   PubMed Web of Science ®Google Scholar
• Yap, C. W. (2011). PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints. Journal of Computational Chemistry, 32(7), 1466–1474. doi:10.1002/jcc.21707
   PubMed Web of Science ®Google Scholar
• Zahler, S., Tietze, S., Totzke, F., Kubbutat, M., Meijer, L., Vollmar, A. M., & Apostolakis, J. (2007). Inverse in silico screening for identification of kinase inhibitor targets. Chemical Biology, 14(11), 1207–1214. doi:10.1016/j.chembiol.2007.10.010
   PubMedGoogle Scholar